Back in Feb IHL engaged EAS Advisors (Eddie Sugar) on a 12 month engagement on the basis of a monthly retainer plus 2 tranches of 10 million options. The purpose of the engagement was to facilitate a listing on the NASDAQ or NYSE, due to the deep investor interest and corporate activity in both cannabis-based pharmaceuticals and psychedelic therapeutic endeavours in North America.
EAS has a strong track record of success and would not have accepted the engagement unless it was supremely confident of success. Nor, would IHL management have engaged EAS at such a significant cost, if it was not totally confident of success.
I anticipate our listing to be completed by the end of Q3. Bring it on.
IHL Price at posting:
25.5¢ Sentiment: Buy Disclosure: Held
